Holen Sie sich die Stockscreener-App
1.30
3.17%
0.04
Vorhandelsmarkt:
1.27
-0.03
-2.31%
Vivani Medical Inc Aktie (VANI) Neueste Nachrichten
Price to earnings forward of Vivani Medical, Inc. – NASDAQ:VANI - TradingView
Vivani Medical Advances SLIM-1 Trial for Obesity Treatment - TipRanks
Form 4 Vivani Medical Inc For: 26 June By Investing.com - Investing.com South Africa
Enterprise value to EBIT forward of Vivani Medical, Inc. – NASDAQ:VANI - TradingView
Enterprise value to EBIT forward of Vivani Medical Inc. – DUS:U5P - TradingView
Vivani Medical Inc. Actuals & Estimates (NASDAQ:VANI) - TradingView
Price to book forward of Vivani Medical, Inc. – NASDAQ:VANI - TradingView
Price to book forward of Vivani Medical Inc. – DUS:U5P - TradingView
Vivani’s Board Overhaul Signals High-Stakes Push into GLP-1 Market - BriefGlance
Vivani Medical appoints August Moretti to board of directors - Investing.com
Vivani Medical appoints August Moretti to board of directors By Investing.com - Investing.com UK
Vivani Medical Announces Appointment of August J. Moretti to Board of Directors and Retirement of Dr. Dean Baker - GlobeNewswire
Price to sales forward of Vivani Medical, Inc. – NASDAQ:VANI - TradingView
Form 4 Vivani Medical Inc For: 25 June By Investing.com - Investing.com Australia
Price to sales forward of Vivani Medical Inc. – DUS:U5P - TradingView
Enterprise value to EBITDA forward of Vivani Medical Inc. – DUS:U5P - TradingView
Price to earnings forward of Vivani Medical Inc. – DUS:U5P - TradingView
Vivani Medical receives approval to start semaglutide implant trial - Investing.com
Vivani Medical (VANI) Secures Approval for Phase 1 Clinical Tria - GuruFocus
Vivani Medical receives approval to start semaglutide implant trial By Investing.com - Investing.com Australia
Vivani Medical Receives Regulatory Approval to Test Potential Weight Loss Drug Implant - marketscreener.com
Vivani Medical Receives Regulatory Approval for the Initiation of SLIM-1, a Phase 1 Clinical Trial of NPM-139 Semaglutide Implant in Obesity and Chronic Weight Management - GlobeNewswire
Vivani Medical Inc (VANI) Institutional Confidence - TradingKey
Vivani Medical Price Target Announced at $4.00/Share by Lake Street - Moomoo
Lake Street Initiates Coverage on Vivani Medical With Buy Rating, $4 Price Target - Moomoo
Lake Street initiates Vivani Medical stock with buy on implant tech - Investing.com South Africa
Vivani Medical CEO Adam Mendelsohn to Present at the 2026 BIO International Convention - GlobeNewswire
Vivani Medical Inc (VANI) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Vivani Medical Inc (VANI) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Vivani Medical Inc (VANI) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Vivani Medical Inc (VANI) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Vivani Medical Inc (VANI) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Vivani Medical Inc (VANI) Valuation: PE, PB & Fair Value Analysis - TradingKey
Vivani Medical Inc (VANI) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Vivani Medical Inc (VANI) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Vivani Medical director Gregg Williams purchases $2 million common stock By Investing.com - Investing.com South Africa
Insider Stock Purchases: June 16, 2026 - Quiver Quantitative
Vivani Medical director Gregg Williams purchases $2 million common stock - Investing.com
Vivani Medical Insider Bought Shares Worth $1,999,999, According to a Recent SEC Filing - marketscreener.com
VANI Q1 2026 Earnings: Narrowed Loss Beat Estimates, Stock Slips Despite ProgressAnalyst Earnings Estimate - newsline.com
VANI Q1 2026 Earnings: Narrower-Than-Expected Loss Drives Modest Stock DeclineEBITDA Margin Trends - newsline.com
Vivani Medical (VANI) Holds Near Support After Slight DeclineForce Index - newsline.com
VANI Q1 2026 Earnings: Narrower-than-expected loss highlights clinical progress in obesity pipelineRevenue Beat Analysis - newsline.com
VANI Stock Price, Quote & Chart - ChartMill
Vivani Medical (VANI) Slips 2.54% as Stock Tests Key Support at $1.09Aggressive Growth Picks - newsline.com
Vivani Medical Inc. (VANI) Q1 2026 Earnings: Narrower-Than-Expected Loss and Pipeline Progress Amidst Stock DeclineProduct Revenue Analysis - newsline.com
Vivani Medical Inc. (VANI) Q1 2026 Earnings: Narrower-Than-Expected Loss as Clinical Preparations Continue - newsline.com
Vivani Medical (VANI) Jefferies Global Healthcare Conference 2026 Summary - Quartr
Vivani Medical Highlights Investor Presentation at Jefferies Conference - TipRanks
Vivani to Present CEO Slide Deck at Jefferies Global Healthcare Conference - TradingView
0.05%
0.74%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):